Results 211 to 220 of about 18,162 (243)

Raltegravir

Nature Reviews Drug Discovery, 2008
* Raltegravir, the first in a new class of orally administered HIV type-1 (HIV-1) integrase inhibitors, selectively inhibits the strand transfer activity of HIV-1 and its integration into human DNA, a key stage in retroviral propagation, thereby limiting viral replication and the infection of new cells.
Steven G Deeks
exaly   +5 more sources

Home - About - Disclaimer - Privacy